These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6610675)

  • 41. Good antimicrobial prescribing. Clinical uses of cephalosporins.
    Neu HC
    Lancet; 1982 Jul; 2(8292):252-5. PubMed ID: 6124680
    [No Abstract]   [Full Text] [Related]  

  • 42. Ceftizoxime and ceftazidime.
    Lancet; 1984 Feb; 1(8371):260. PubMed ID: 6143000
    [No Abstract]   [Full Text] [Related]  

  • 43. [Cephalosporins--microbiological bases for their utilization in therapy (author's transl)].
    Výmola F; Jedlicková Z
    Cas Lek Cesk; 1976 May; 115(20-21):606-8. PubMed ID: 1277244
    [No Abstract]   [Full Text] [Related]  

  • 44. [The current importance of semisynthetic cephalosporins in the antibiotic therapy of bacterial infections (informational data)].
    Treskina OS; Navashin SM
    Antibiot Khimioter; 1988 Nov; 33(11):850-5. PubMed ID: 3228329
    [No Abstract]   [Full Text] [Related]  

  • 45. [Cefuroxime, a new antibiotic. Action in vitro and in vivo].
    Orsolini P; Xerri L
    G Ital Chemioter; 1977; 24(1-2):49-55. PubMed ID: 615762
    [No Abstract]   [Full Text] [Related]  

  • 46. [Clinical experience with flomoxef in the pediatric field].
    Sekiguchi T; Okamoto T; Ohara K; Miyauchi Y; Kawahito S; Saijyo T
    Jpn J Antibiot; 1987 Aug; 40(8):1469-76. PubMed ID: 3430722
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Review of oral cephalosporins. Basis for a rational choice].
    Forti IN
    Medicina (B Aires); 1994; 54(5 Pt 1):439-58. PubMed ID: 7658980
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical examination of cefoperazone in pediatrics (author's transl)].
    Matsuda H; Yoshida T; Kagata N; Niino S
    Jpn J Antibiot; 1980 Sep; 33(9):935-40. PubMed ID: 6452543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A clinical study on cefdinir in pediatrics].
    Satoh Y; Iwata S; Akita H; Sunakawa K
    Jpn J Antibiot; 1990 Oct; 43(10):1796-805. PubMed ID: 2086817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Fundamental and clinical studies on ceftazidime in the field of paediatrics].
    Nakamura T; Seto S; Kimura K; Sato K; Sato H; Fukuda F; Nishikawa S
    Jpn J Antibiot; 1984 Mar; 37(3):485-9. PubMed ID: 6376857
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cephazolin: bacteriological study and clinical results].
    Bertrand A; Janbon F; Despaux E; Jourdan J
    Nouv Presse Med; 1974 Apr; 3(0):28-32. PubMed ID: 4599827
    [No Abstract]   [Full Text] [Related]  

  • 52. Seminar on antibiotics IV. The cephalosporins.
    Rhoades ER
    J Okla State Med Assoc; 1980 Oct; 73(10):360-2. PubMed ID: 7431140
    [No Abstract]   [Full Text] [Related]  

  • 53. Antibacterial activity of cefotaxime.
    Mitsuhashi S; Inoue M; Masuyoshi S
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():37-46. PubMed ID: 6252177
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical and pharmacokinetic evaluations of cefuzonam in children].
    Meguro H; Arimasu O; Shiraishi H; Kobayashi M; Fuji R; Mashiko J
    Jpn J Antibiot; 1987 Mar; 40(3):630-40. PubMed ID: 3613083
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The cephalosporins. I].
    Fossati C
    Clin Ter; 1978 Jan; 84(2):167-93. PubMed ID: 348382
    [No Abstract]   [Full Text] [Related]  

  • 56. Use of cefoxitin sodium in difficult-to-treat infections.
    Ramachandran Nair S; Cherubin CE
    J Antimicrob Chemother; 1978 Jul; 4(B):167-78. PubMed ID: 357383
    [No Abstract]   [Full Text] [Related]  

  • 57. [Reevaluation of current antimicrobials. cefdinir (discussion)].
    Jpn J Antibiot; 1995 Jun; 48(6):733-40. PubMed ID: 7666577
    [No Abstract]   [Full Text] [Related]  

  • 58. Comparative activity of two newer cephalosporins, cefoxitin, and cephalothin against selected Enterobacteriaceae and correlation with enzymatic resistance mechanisms.
    Vuye A; Pijck J; Van Landuyt HW
    J Antimicrob Chemother; 1979 May; 5(3):293-300. PubMed ID: 314440
    [No Abstract]   [Full Text] [Related]  

  • 59. [Laboratory and clinical studies on cefdinir in pediatric field].
    Nakao Y; Andoh Y; Kitoh O; Takeuchi H; Hayakawa F; Ogawa A; Kuno K
    Jpn J Antibiot; 1990 Aug; 43(8):1476-88. PubMed ID: 2283718
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Beta-lactamase inhibition: therapeutic implications in infectious diseases--an overview.
    Moellering RC
    Rev Infect Dis; 1991; 13 Suppl 9():S723-6. PubMed ID: 1925316
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.